Abstract
Current glucose monitoring techniques for neonates rely heavily on blood glucose monitors which require intermittent blood collection through skin-penetrating pricks on the heel or fingers. This procedure is painful and often not clinically conducive, which presents a need for a noninvasive method for monitoring glucose in neonates. Our motivation for this study was to develop an in vitro method for measuring passive diffusion of glucose in premature neonatal skin using a porcine skin model. Such a model will allow us to initially test new devices for noninvasive glucose monitoring without having to do in vivo testing of newborns. The in vitro model is demonstrated by comparing uncompromised and tape-stripped skin in an in-line flow-through diffusion apparatus with glucose concentrations that mimic the hypo-, normo-, and hyper-glycemic conditions in the neonate (2.0, 5.0, and 20 mM, respectively). Transepidermal water loss (TEWL) of the tape-stripped skin was approximately 20 g m−2 h−1, which closely mimics TEWL for neonatal skin at about 190 days post-conceptional age. The tape-stripped skin showed a >15-fold increase in glucose diffusion compared to the uncompromised skin. The very small concentrations of collected glucose were measured with a highly selective and highly sensitive fluorescent glucose biosensor based on the glucose binding protein (GBP). The demonstrated method of glucose determination is noninvasive and painless, which makes it especially desirable for glucose testing in neonates and children. This study is an important step towards an in vitro model for noninvasive real-time glucose monitoring that may be easily transferred to the clinic for glucose monitoring in neonates.
Similar content being viewed by others
References
Woo HC, Tolosa L, El-Metwally D, Viscardi RM. Glucose monitoring in neonates: need for accurate and non-invasive methods. Arch Dis Child Fetal Neonatal Ed. 2014;99:F153–7. http://fn.bmj.com/content/99/2/F153.long.
Tierney MJ, Tamada JA, Potts RO, Eastman RC, Pitzer K, Ackerman NR, et al. The GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor. Ann Med. 2000;32:632–41. http://www.ncbi.nlm.nih.gov/pubmed/11209971.
Tierney MJ, Tamada JA, Potts RO, Jovanovic L, Garg S. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens. Bioelectron. 2001;16:621–9.
Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115–24. http://www.ncbi.nlm.nih.gov/pubmed/15040576.
Mitragotri S, Coleman M, Kost J, Langer R. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels. J Appl Physiol. 2000;89:961–6.
Huang Y-B, Fang J-Y, Wu P-C, Chen T-H, Tsai M-J, Tsai Y-H. Noninvasive glucose monitoring by back diffusion via skin: chemical and physical enhancements. Biol Pharm Bull. 2003;26:983–7. Available from: http://bpb.pharm.or.jp/bpb/200307/b07_0983.pdf%5Cn, http://www.ncbi.nlm.nih.gov/pubmed/12843623.
Tiberi E, Cota F, Barone G, Perri A, Romano V, Iannotta R, et al. Continuous glucose monitoring in preterm infants : evaluation by a modified Clarke error grid. Ital. J. Pediatr. [Internet]. Italian Journal of Pediatrics; 2016; 1–7. Available from: doi:10.1186/s13052-016-0236-9.
Baca JT, Finegold DN, Asher SA. Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus. Ocul Surf. 2007;5:280–93.
Badugu R, Lakowicz JR, Geddes CD. A glucose-sensing contact lens: from bench top to patient. Curr. Opin. Biotechnol. 2005. 100–7.
Guo D, Zhang D, Zhang L, Lu G. Non-invasive blood glucose monitoring for diabetics by means of breath signal analysis. Sensors Actuators B Chem. 2012;173:106–13.
Soni A, Jha SK. A paper strip based non-invasive glucose biosensor for salivary analysis. Biosens Bioelectron. 2015;67:763–8.
Zhang W, Du Y, Wang ML. Noninvasive glucose monitoring using saliva nano-biosensor. Sens Bio-Sensing Res. 2015;4:23–9.
Jia MY, Wu QS, Li H, Zhang Y, Guan YF, Feng L. The calibration of cellphone camera-based colorimetric sensor array and its application in the determination of glucose in urine. Biosens Bioelectron. 2015;74:1029–37.
Liu G, Ho C, Slappey N, Zhou Z, Snelgrove SE, Brown M, et al. A wearable conductivity sensor for wireless real-time sweat monitoring. Sensors Actuators B Chem. 2016;227:35–42.
Xiao T, Wang XY, Zhao ZH, Li L, Zhang L, Yao HC, et al. Highly sensitive and selective acetone sensor based on C-doped WO3 for potential diagnosis of diabetes mellitus. Sensors Actuators B-Chem. 2014;199:210–9.
Ge X, Rao G, Kostov Y, Kanjananimmanont S, Viscardi RM, Woo H, et al. Detection of trace glucose on the surface of a semipermeable membrane using a fluorescently labeled glucose-binding protein: a promising approach to noninvasive glucose monitoring. J Diabetes Sci Technol. 2013;7:4–12. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3692211&tool=pmcentrez&rendertype=abstract.
Ge X, Tolosa L, Rao G. Dual-labeled glucose binding protein for ratiometric measurements of glucose. Anal Chem. 2004;76:1403–10.
Tolosa L, Gryczynski I, Eichhorn LR, Dattelbaum JD, Castellano FN, Rao G, et al. Glucose sensor for low-cost lifetime-based sensing using a genetically engineered protein. Anal Biochem. 1999;267:114–20. http://www.ncbi.nlm.nih.gov/pubmed/9918662.
Rao G, Ph D, Tolosa L. Comparing the performance of the optical glucose assay based on glucose binding protein with high-performance anion-exchange chromatography with pulsed electrochemical detection: efforts to design a low-cost point-of-care glucose sensor. J Diabetes Sci Technol. 2007;1:864–72.
Amiss TJ, Sherman DB, Nycz CM, Andaluz SA, Pitner JB. Engineering and rapid selection of a low-affinity glucose/galactose-binding protein for a glucose biosensor. Protein Sci. 2007;16:2350–9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2211708&tool=pmcentrez&rendertype=abstract.
de Lorimier RM, Tian Y, Hellinga HW. Binding and signaling of surface-immobilized reagentless fluorescent biosensors derived from periplasmic binding proteins. Protein Sci. 2006;15:1936–44.
Fonin AV, Stepanenko OV, Povarova OI, Volova CA, Philippova EM, Bublikov GS, et al. Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors. Peer J. 2014;2:e275. https://peerj.com/articles/275.
Khan F, Saxl TE, Pickup JC. Fluorescence intensity- and lifetime-based glucose sensing using an engineered high-Kd mutant of glucose/galactose-binding protein. Anal. Biochem. [Internet]. Elsevier Inc.; 2010;399:39–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19961827.
Pickup JC, Khan F, Zhi Z-L, Coulter J, Birch DJS. Fluorescence intensity- and lifetime-based glucose sensing using glucose/galactose-binding protein. J Diabetes Sci Technol. 2013;7:62–71. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3692217&tool=pmcentrez&rendertype=abstract.
Scognamiglio V, Aurilia V, Cennamo N, Ringhieri P, Iozzino L, Tartaglia M, et al. D-galactose/D-glucose-binding protein from Escherichia coli as probe for a non-consuming glucose implantable fluorescence biosensor. Sensors. 2007;7:2484–91. Available from: http://www.mdpi.com/1424-8220/7/10/2484/.
Kostov Y, Ge X, Rao G, Tolosa L. Portable system for the detection of micromolar concentrations of glucose. Meas Sci Technol. 2014;25:25701. http://www.ncbi.nlm.nih.gov/pubmed/24587594.
Kanjananimmanont S, Ge X, Mupparapu K, Rao G, Potts R, Tolosa L. Passive diffusion of transdermal glucose: noninvasive glucose sensing using a fluorescent glucose binding protein. J Diabetes Sci Technol. 2014;8:291–8. http://www.ncbi.nlm.nih.gov/pubmed/24876581.
Fujii M, Yamanouchi S, Hori N, Iwanaga N, Naruko K, Matsumoto M. Evaluation of Yucatan micropig skin for use as an in vitro model for skin permeation study. Biol Pharm Bull. 1997;20:249–54.
Takeuchi H, Terasaka S, Sakurai T, Furuya A, Urano H, Sugibayashi K. Variation assessment for in vitro permeabilities through Yucatan micropig skin. Biol Pharm Bull. 2011;34:555–61. http://www.ncbi.nlm.nih.gov/pubmed/21467645.
Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol. Vitr. 2009. 1–13.
Sekkat N, Kalia YN, Guy RH. Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates. Pharm Res. 2004;21:1390–7.
Sekkat N, Kalia YN, Guy RH. Development of an in vitro model for premature neonatal skin: Biophysical characterization using transepidermal water loss. J Pharm Sci. 2004;93:2936–40.
Khan F, Gnudi L, Pickup JC. Fluorescence-based sensing of glucose using engineered glucose/galactose-binding protein: a comparison of fluorescence resonance energy transfer and environmentally sensitive dye labelling strategies. Biochem Biophys Res Commun. 2008;365:102–6.
34. Milewski M, Yerramreddy TR, Ghosh P, Crooks P a, Stinchcomb AL. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. J. Control. Release [Internet]. Elsevier B.V.; 2010 [cited 2014 Feb 21];146:37–44. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2916235&tool=pmcentrez&rendertype=abstract.
Reddy MB, Stinchcomb AL, Guy RH, Bunge AL. Determining dermal absorption parameters in vivo from tape strip data. Pharm Res. 2002;19:292–8.
Kalia YN, Nonato LB, Lund CH, Guy RH. Development of skin barrier function in premature infants. J. Invest. Dermatol. [Internet]. Elsevier Masson SAS; 1998;111:320–6. Available from: doi:10.1046/j.1523-1747.1998.00289.x
Netzlaff F, Kostka KH, Lehr CM, Schaefer UF. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing. Eur J Pharm Biopharm. 2006;63:44–50.
Machado M, Salgado TM, Hadgraft J, Lane ME. The relationship between transepidermal water loss and skin permeability. Int J Pharm. 2010;384:73–7.
Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release. 2005;103:291–9. http://www.ncbi.nlm.nih.gov/pubmed/15763614.
Dey S, Rothe H, Page L, O’Connor R, Farahmand S, Toner F, et al. An in vitro skin penetration model for compromised skin: estimating penetration of polyethylene glycol [14C]-PEG-7 phosphate. Skin Pharmacol Physiol. 2015;28:12–21.
41. Escobar-Chávez JJ, Rodriguez-Cruz IM, Dominguez-Delgado CL. Chemical and physical enhancers for transdermal drug delivery [Internet]. Pharmacology. 2012 [cited 2014 Jul 22]. Available from: http://cdn.intechopen.com/pdfs/32136.pdf.
Acknowledgements
The authors acknowledge Science, Technology, Research and Innovation for Development (STRIDE) Program of USAID for Cristina Tiangco’s research support. They would also like to thank Sean Najmi for helping with the experimental work and UMB-UMBC for seed funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
There are no conflicts of interest that exist for this manuscript.
Yucatan minipig skin was purchased from Sinclair BioResources. Sinclair complies with a number of agencies. They are USDA licensed as a breeder (43-A-5793). The company is in full compliance with the Animal Welfare Act and has maintained accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International) since 1995. Further information can be found on their website www.sinclairbioresources.com/about-us/facilities/ and can be contacted directly via email: info@sinclairbioresources.com, or phone: 573-387-4400.
Additional information
Cristina Tiangco and Abhay Andar contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tiangco, C., Andar, A., Quarterman, J. et al. Measuring transdermal glucose levels in neonates by passive diffusion: an in vitro porcine skin model. Anal Bioanal Chem 409, 3475–3482 (2017). https://doi.org/10.1007/s00216-017-0289-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-017-0289-7